HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Olga Lvova Selected Research

Dabigatran

11/2022Dabigatran in the treatment and secondary prophylaxis of venous thromboembolism in children with thrombophilia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Olga Lvova Research Topics

Disease

2Venous Thromboembolism
11/2022 - 01/2020
2Hemorrhage
12/2020 - 01/2020
1Thrombophilia
11/2022
1Thrombosis (Thrombus)
11/2022
1Venous Thrombosis (Deep-Vein Thrombosis)
12/2020

Drug/Important Bio-Agent (IBA)

3AnticoagulantsIBA
11/2022 - 01/2020
2RivaroxabanIBA
12/2020 - 01/2020
1Prothrombin (Factor II)IBA
11/2022
1DabigatranFDA Link
11/2022
1Antiphospholipid AntibodiesIBA
11/2022
1factor V LeidenIBA
11/2022
1Protein CIBA
11/2022
1AntithrombinsIBA
11/2022
1Heparin (Liquaemin)FDA LinkGeneric
01/2020
1SuspensionsIBA
01/2020
1TabletsIBA
01/2020
1Vitamin KFDA Link
01/2020

Therapy/Procedure

1Secondary Prevention
11/2022
1Catheters
01/2020